Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
CBD Crew is a cannabis genetics and seed company focused on developing and commercializing stable CBD-rich and balanced CBD/THC cannabis seeds. The company presents itself as a joint venture between Mr. Nice Seedbank and Resin Seeds, with an emphasis on varieties intended for medical patients as well as recreational growers seeking reproducible cannabinoid profiles. Its offerings are sold as seed varieties rather than regulated pharmaceutical drug candidates, and the business appears centered on breeding, seed distribution, and educational content about cannabidiol and cannabis. CBD Crew highlights lab-tested cannabinoid ratios and markets strains such as CBD Therapy, CBD Critical Mass, and CBD SharkShock. The company is best characterized as a commercial cannabis seed brand operating adjacent to healthcare rather than a traditional biotech or pharmaceutical developer.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on CBD Crew.